Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Research
Ring's 'new class of viral vector' is re-dosable in primates
New data presented at ASGCT show Ring’s Anellovectors infect and express a transgene in the primate retina and can be re-dosed at higher levels.
Helen Floersh
May 8, 2024 5:05pm
Experts: To improve trial diversity, look to informed consent
May 8, 2024 2:45pm
Sponsored
Progress Toward a New GAD Treatment Paradigm
May 6, 2024 8:00am
How Peter Marks plans to prevent '3 billion visits' to FDA
May 8, 2024 11:05am
Sponsored
Patient Access and Affordability: PhRMA shares how we can put patients first
Feb 12, 2024 8:00am
Sanofi CSO Frank Nestle is leaving
May 8, 2024 10:00am